Global Oligonucleotide Synthesis Market is estimated to be US$ 26.4 Billion by 2030 with a CAGR of 16.9%


Posted October 13, 2021 by Nisha0914

The Global Oligonucleotide Synthesis Market accounted for US$ 5.5 billion in 2020 and is estimated to be US$ 26.4 billion by 2030 and is anticipated to register a CAGR of 16.9%.

 
The Global Oligonucleotide Synthesis Market accounted for US$ 5.5 billion in 2020 and is estimated to be US$ 26.4 billion by 2030 and is anticipated to register a CAGR of 16.9%. Oligonucleotide synthesis is that the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and cheap access to custom-made oligonucleotides of the specified sequence. Whereas enzymes synthesize DNA and RNA only during a 5' to 3' direction, chemical oligonucleotide synthesis doesn't have this limitation, although it's most frequently administered within the opposite, 3' to 5' direction. Currently, the method is implemented as solid-phase synthesis using phosphoramidite method and phosphoramidite building blocks derived from protected 2'-deoxynucleosides (dA, dC, dG, and T), ribonucleosides (A, C, G, and U), or chemically modified nucleosides.

The report " Global Oligonucleotide Synthesis Market, By Product Type (Synthesized Oligonucleotide Product, Reagents and Equipment), By Type (Custom Oligos and Predesigned Oligos), By Application (Research, Diagnostics, and Therapeutics), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:

On 29th June 2021, DNA Script has launched their SYNTAX platform with their first product, the SYNTAX System, the first benchtop nucleic acid printer powered by Enzymatic DNA Synthesis (EDS) technology. The SYNTAX System is a fully integrated, automated printer that synthesizes 96 DNA oligos in parallel, comprised of up to 60 nucleotides in length, and delivers them ready for use in molecular biology and genomics workflows, without the need for additional handling.
In 2019, Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced the launch of its long oligonucleotides, or oligos, product line. At up to 300 bases, or nucleotides, in length this is the longest commercial oligo offering by continuous chemical synthesis in the industry. Twist believes that these synthetic oligos will increase the success and productivity of biological research.
Analyst View:

Developing clinical applications, for example, the nucleic corrosive application strategies are the reference techniques and are entirely important for completing atomic finding in a few sicknesses like location of irresistible infections, like hepatitis. Besides, oligonucleotide blend is a fundamental piece of a few continuous hereditary examination contemplates. Thusly the developing interests in hereditary examination are relied upon to push interest for custom amalgamation of various classes of oligos including imitations, aptamers, immunostimulatory, antisense, siRNA, and miRNA.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Oligonucleotide Synthesis Market, By Product Type (Synthesized Oligonucleotide Product, Reagents and Equipment), By Type (Custom Oligos and Predesigned Oligos), By Application (Research, Diagnostics, and Therapeutics), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Oligonucleotide-Synthesis-Market-By-3777

Key Market Insights from the report:

The Global Oligonucleotide Synthesis Market accounted for US$ 5.5 billion in 2020 and is estimated to be US$ 26.4 billion by 2030 and is anticipated to register a CAGR of 16.9%. The Global Oligonucleotide Synthesis Market is segmented based on the Product type, type, application and region.

By Product Type, the Global Oligonucleotide Synthesis Market is segmented into Synthesized Oligonucleotide Product, Reagents and Equipment.
By Type, the Global Oligonucleotide Synthesis Market is segmented into Custom Oligos and Predesigned Oligos.
By Application, the Global Oligonucleotide Synthesis Market is segmented into Research, Diagnostics, and Therapeutics.
By region, the Global Oligonucleotide Synthesis Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the worldwide leader in the Oligonucleotide Synthesis market in terms of revenue, due to the developed healthcare system and health awareness among people.
Competitive Landscape:

The key players operating the global Oligonucleotide synthesis market involves Agilent Technologies, Inc., ATDBio Ltd., Bio-Synthesis, Inc., BioAutomation Corporation, LGC Biosearch Technologies, Biogen International, Sarepta Therapeutics, Eurofins Genomics, Eurogentec, GeneDesign, Inc., GE Healthcare, and GenScript, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered

Introduction
Study Deliverables
Study Assumptions
Scope of the Study
Research Methodology
Executive Summary
Opportunity Map Analysis
Market at Glance
Market Share (%) and BPS Analysis, by Region
Competitive Landscape
Heat Map Analysis
Market Presence and Specificity Analysis
Investment Analysis
Competitive Analysis
To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Prophecy Market Insights
Phone 7775049802
Business Address 964 E. Badillo Street #2042
Country United States
Categories Biotech
Tags global oligonucleotide synthesis market , oligonucleotide synthesis , oligonucleotide synthesis market
Last Updated October 13, 2021